Article
Odyssey Medical has introduced a punctal plug (Micro Flow) that is designed to provide a reversible means of partial occlusion by limiting the drainage of tears into the lacrimal duct.
Memphis, TN
-Odyssey Medical has introduced a punctal plug (Micro Flow) that is designed to provide a reversible means of partial occlusion by limiting the drainage of tears into the lacrimal duct. The device is intended for use in patients who have epiphora caused by a punctal stenosis or in instances where total punctal occlusion is considered too aggressive an approach.
In three sizes (small, medium, and large), the plug is available in sterile pre-loaded packaging that includes one pair of occluders and in non-sterile bulk packaging that includes five pairs.
In other news, the company announced results of a study showing a 92% retention rate for another occluder (Parasol). When Craig McCabe, MD, PhD, examined 108 patients who received the plug after artificial tears had failed to address their dry eye, 91% of them reported that their eyes had more moisture, and 77% reported fewer dry eye symptoms. Snellen acuity improved by one or more lines in 43% of the eyes, according to the company.